close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of (NY:FMS)

23.39 -0.04 (-0.19%)
Streaming Delayed Price Updated: 1:09 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of

< Previous 1 2 3 4 Next >
News headline image
Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript ↗
U.S. referral execution gap offset by strong margin expansion and transformation savings. 
Via The Motley Fool
Topics Earnings
News headline image
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights ↗
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) reported second-quarter 2026 organic revenue growth of 5% and a 23% increase in operating income at constant currency, while confirming its full-year... 
Via MarketBeat
Topics Earnings
News headline image
Fresenius (FMS) Q1 2026 Earnings Transcript ↗
Fresenius (FMS) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
The Dialysis Renaissance: How DaVita (DVA) Conquered the GLP-1 Fear and Defined Healthcare Resilience in 2026
Date: February 11, 2026 Introduction In the first few weeks of 2026, a singular healthcare name has dominated the screens of institutional traders and retail investors alike: DaVita Inc. (NYSE: DVA).... 
Via Finterra
Topics Bankruptcy Earnings Retirement
News headline image
This Fortinet Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum ↗
FDA approves Amphastar's iron sucrose injection for CKD-associated anemia, with potential for $80-100 million sales and a 2025 launch. 
Via Benzinga
News headline image
Dollar's Worst Start Since 1970s Could Dent European Corporate Profits ↗
 
Via Benzinga
News headline image
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
Topics Cannabis
News headline image
Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency ↗
Fresenius Medical Care outlines new strategy with 5008X machine rollout in the U.S., launch of Value-Based Care segment, and cost-saving goals through FME25+. 
Via Benzinga
News headline image
5 Stocks To Ride The German Market Rally ↗
 
Via Benzinga
News headline image
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence ↗
Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; full-year guidance for sales and EPS reaffirmed. 
Via Benzinga
News headline image
Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
5 Classic Value Stocks For 2025 ↗
Alaska Air Group had a big year in 2024 as it closed on its deal for Hawaiian Airlines in September. It now flies to over 141 destinations. 
Via Talk Markets
Topics Stocks / Equities
News headline image
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
News headline image
Current Analysis: Fresenius Medical Care (FMS) ↗
Fresenius Medical Care (FMS​​​​​​​) is the largest dialysis company in the world. Over the past year, Fresenius's share price fell just over 30% from $26.09 to $18.14 as of Monday’s market close. 
Via Talk Markets
News headline image
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Stock Analysis: Fresenius Medical Care ↗
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. 
Via Talk Markets
News headline image
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway ↗
You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on. 
Via InvestorPlace
News headline image
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers ↗
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... 
Via Benzinga
News headline image
Current Analysis: Fresenius Medical Care ↗
Fresenius Medical Care is the largest dialysis company in the world and a leading supplier of dialysis products, including machines, dialyzers, and concentrates. 
Via Talk Markets
Topics Supply Chain
News headline image
FMS Stock Earnings: Fresenius Medical Care Beats EPS, Beats Revenue for Q1 2024 ↗
FMS stock results show that Fresenius Medical Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session ↗
 
Via Benzinga
News headline image
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Why Are Dialysis Provider Stocks Trading Higher On Tuesday? ↗
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.